Illumina has launched the Illumina 5-Base Solution for Cancer Research Grant Contest, a new grant program designed to support cancer research using integrated genomic and epigenomic analysis.
The contest invites eligible researchers to submit a 400-word abstract proposing a new cancer focused study using the Illumina 5-base solution, including Illumina 5-Base DNA Prep or Illumina 5-Base DNA Prep with Enrichment. One winner, selected by a panel of Illumina scientists and executives, will receive kits and core consumables sufficient for up to 1000 samples.
Key details:
- Submission deadline: June 26, 2026 (11:59 pm PT)
- Winner announcement: July 29, 2026
- Eligibility: Basic scientists doing cancer research, using NGS
- Focus: Integrated analysis of genetic and epigenetic variation in cancer research
Beyond the award, the program provides opportunities for researcher visibility through Illumina sponsored or approved activities such as webinars, case studies, blog posts, posters, or presentations.